+467.0%
MRNA vs EXPE
+30.8%
+436.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXPE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +5.0% |
| 7D | -1.1% | -5.8% | +4.7% | +0.4% |
| 30D | +126.1% | -13.6% | +139.7% | +134.2% |
| 3M | +190.0% | +25.2% | +164.8% | +183.3% |
| 6M | +157.2% | +22.3% | +134.9% | +149.9% |
| YTD | +388.2% | -0.3% | +388.5% | +399.9% |
| 1Y | +467.0% | +27.8% | +439.2% | +452.4% |
| All | +467.0% | +30.8% | +436.2% | +452.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EXPE.
Daily Out/Under-Performance
Portfolio return minus EXPE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXPE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXPE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling